Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
More than 8,300 Hair Relaxer Lawsuits Over Uterine Cancer, Ovarian Cancer, Other Injuries Pending in Federal MDL Lawyers are scheduled to meet with the judge presiding over the hair relaxer lawsuits this week, as plaintiffs accuse manufacturers of engaging in an effort to unnecessarily delay the litigation and start of bellwether trials. March 5, 2024 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all hair relaxer lawsuits filed throughout the federal court system is scheduled to meet with lawyers involved in the litigation on March 7, as the size and scope of the litigation continues to increase, and parties disagree on the timing and process for selecting a small group of reprsentative claims to prepare for early bellwether trials. According to a docket report (PDF) released on March 1, there are currently at least 8,334 product liability lawsuits filed by women who indicate that they developed uterine cancer, ovarian cancer, fibroids or other injuries that were caused by exposure to endocrine disrupting chemicals in Dark & Lovely, Just for Me, Optimum, ORS Olive Oil and other chemical hair straighteners that have been frequently used by African American women for decades. The litigation emerged in late 2022, following the publication of a study that highlighted a link between use of hair relaxer and uterine cancer, finding that women who regularly used the products face a 156% increased risk compared to women who did not use hair relaxers. As a result of those findings, women throughout the U.S. began filing Dark & Lovely lawsuits, Just for Me lawsuits and similar claims against the makers of other popular hair relaxers, seeking financial compensation from the manufacturers, each raising similar allegations that a desire for profits was placed before the health of consumers. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in hair relaxer lawsuits filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established coordinated pretrial proceedings in the Northern District of Illinois under U.S. District Judge Mary Rowland in January 2023, who has been presiding over coordinated discovery into common issues that impact all claims and indicated that a “bellwether” program will be established to prepare a small group of representative cases for early trial dates. While the outcomes of these early bellwether trials will not have any binding impact on other claims, they are expected to drive potential hair relaxer settlement negotiations by helping the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. Hair Relaxer Lawsuit Bellwether Selection Dispute Ahead of a case management conference scheduled for Thursday, the parties filed a joint status report (PDF) on March 1, updating the Court on the status of the litigation and outlining a number of disputes that have arisen regarding the timing and process for selecting bellwether claims. In the report, the manufacturers called for delays and changes to the selection process, by arguing that plaintiffs have been slow to sufficiently complete Plaintiff Fact Sheets (PFS), which are written statements intended to provide certain information about each claim. The defendants claim that incomplete PFS in a number of recently filed claims will impact their ability to determine the most appropriate bellwether selections. However, plaintiffs indicate that with thousands of claims filed, the manufacturers are overstating the impact of the problem and have unreasonable expectations, indicating that the court-established deadline for most of the claimants to complete fact sheets just passed three weeks ago. In addition, with thousands of fact sheets already fully complete, the plaintiffs maintain there are plenty of claims for the parties to make representative selections for the early trial dates. “Defendants appear adamant about delaying this litigation; first, in their own discovery obligations which has been atrocious and now, by claiming the individual plaintiff PFS, due less than three weeks ago, are somehow poised to delay this litigation,” plaintiffs responded. “This is nothing more than a manufactured argument that is not ripe yet but was clearly crafted in the days before the JSR (joint status report) was due in an effort to suggest to the Court that the bellwether process should be further delayed. This is underscoring the theme of delay-delay-delay.” Plaintiffs indicate in the filing that the manufacturers are attempting to seize on a tiny fraction of cases where the fact sheets were not served by the deadlines, in asking the court to further extend the litigation. However, they maintain that this will have no impact on the selection of representative cases for bellwether work-up and ultimate trial dates in the MDL. March 2024 Hair Relaxer Lawsuit Update In November, parties proposed competing draft hair relaxer lawsuit bellwether trial plans, which outlined a process for selecting potential bellwether cases and putting them through case-specific discovery in preparation for early trial dates. However, the parties have been unable to agree on several key points regarding the bellwether selections, as well as when the first trials should begin, and how big a factor general causation should play in the early phases of the litigation. Following the March 2024 hair relaxer lawsuit status conference, it is expected that Judge Rowland will issue a case management order establishing how the litigation will move forward. While the stated intention of bellwether trials is to identify the most representative lawsuits, parties in complex litigation often jockey to make selections that are most beneficial to their side, as the average hair relaxer lawsuit payouts will have a substantial impact on the amount of money the manufacturers may be required to pay to avoid the need for thousands of individual cases to go before separate juries nationwide. Following coordinated discovery in the MDL and any early bellwether trials, if the parties fail to negotiate hair relaxer settlements for individuals diagnosed with uterine cancer, endometrial cancer, ovarian cancer, uterine fibroids and other complications, Judge Rowland may later remand each individual lawsuit directly filed in the MDL back to the U.S. District Court where it would have originated for a separate trial. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Endocrine Disruptors, Endometrial Cancer, Endometriosis, Hair Relaxer, Hair Straighteners, L'Oreal, Ovarian Cancer, Perm, Phthalates, Uterine Cancer, Uterine Fibroids Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 September 11, 2025 Uterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study July 8, 2025 Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)